Cited by 841Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Open access

Ridker, Paul M, Paynter, Nina P., Rifai, Nader, Gaziano, J. Michael, Cook, Nancy R.·2008·Circulation

DOI 10.1161/circulationaha.108.814251PMC PMC2752381

Open this paper in CoChat — free account Open PDF

Abstract

Background— High-sensitivity C-reactive protein and family history are independently associated with future cardiovascular events and have been incorporated into risk prediction models for women (the Reynolds Risk Score for women); however, no cardiovascular risk prediction algorithm incorporating these variables currently exists for men. Methods and Results— Among 10 724 initially healthy American nondiabetic men who were followed up prospectively over a median period of 10.8 years, we compared the test characteristics of global model fit, discrimination, calibration, and reclassification in 2 prediction models for incident cardiovascular events, one based on age, blood pressure, smoking status, total cholesterol, and high-density lipoprotein cholesterol (traditional model) and the other based on these risk factors plus high-sensitivity C-reactive protein and parental history of myocardial infarction before age 60 years (Reynolds Risk Score for men). A total of 1294 cardiovascular events accrued during study follow-up. Compared with the traditional model, the Reynolds Risk Score had better global fit (likelihood ratio test P <0.001), a superior (lower) Bayes information criterion, and a larger C-index ( P <0.001). For the end point of all cardiovascular events, the Reynolds Risk Score for men reclassified 17.8% (1904/10 724) of the study population (and 20.2% [1392/6884] of those at 5% to 20% 10-year risk) into higher- or lower-risk categories, with markedly improved accuracy among those reclassified. For this model comparison, the net reclassification index was 5.3%, and the clinical net reclassification index was 14.2% (both P <0.001). In models based on the Adult Treatment Panel III preferred end point of coronary heart disease and limited to men not taking lipid-lowering therapy, 16.7% of the study population (and 20.1% of those at 5% to 20% 10-year risk) were reclassified to higher- or lower-risk groups, again with significantly improved global fit, larger C-index ( P <0.001), and markedly improved accuracy among those reclassified. For this model, the net reclassification index was 8.4% and the clinical net reclassification index was 15.8% (both P <0.001). Conclusions— As previously shown in women, a prediction model in men that incorporates high-sensitivity C-reactive protein and parental history significantly improves global cardiovascular risk prediction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.814251

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,156
Self-citation
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Self-citation

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 2

10.1161/circ.86.5.1330360 · DOI
10.1161/hyp.39.1.105 · DOI

Sorted by citations

Items 501–600 of 840

Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases
Rollefstad, S., Ikdahl, E., Hisdal, J., Kvien, T. K., Pedersen, T. R., & Semb, A. G. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00080 · Cited by 9
2018 Cholesterol Guidelines: Key Topics in Primary Prevention
Clark, D., & Virani, S. S. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0776-8 · Cited by 9
The Relationship Between the Effectiveness of Blood Pressure Control and Telomerase Reverse Transcriptase Concentration, Adipose Tissue Hormone Concentration and Endothelium Function in Hypertensives
Martynowicz, H., Gać, P., Kornafel-Flak, O., Filipów, S., Łaczmański, Ł., Sobieszczańska, M. I., Mazur, G. J., & Poręba, R. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.012 · Cited by 9
Development of a high-performing, cost-effective and inclusive Afrocentric predictive model for stroke: a meta-analysis approach
Nweke, M., Oyirinnaya, P., Nwoha, P. U., Mitha, S. B., Mshunqane, N., Govender, N., Ukwuoma, M., & Ibeneme, S. C. (2025) · BMC Neurology · doi:10.1186/s12883-025-04229-x · Cited by 9
European Atherosclerosis Society Screening Recommendations for Lipoprotein(a) and High-Sensitivity C-Reactive Protein: Double Standard or Failure of Evidence-Based Medicine?
Goldhaber, S. Z. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152694 · Cited by 9
Additional value of a combined genetic risk score to standard cardiovascular stratification
Pereira, A., Mendonça, M. I., Borges, S., Sousa, A. C., Freitas, S., Henriques, E., Rodrigues, M. F., Freitas, A. I., Guerra, G., Freitas, C., et al. (2018) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2017-0173 · Cited by 9
Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study
Baker, L. H., Boonstra, P. S., Reinke, D. K., Antalis, E. P., Zebrack, B., & Weinberg, R. L. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.36 · Cited by 9
Lower arterial stiffness and Framingham score after switching abacavir to tenofovir in men at high cardiovascular risk
Sinn, K., Richardson, R., & Carr, A. D. (2010) · AIDS · doi:10.1097/qad.0b013e32833d568f · Cited by 9
Evaluating a New Risk Marker's Predictive Contribution in Survival Models
Liu, M., Kapadia, A. S., & Etzel, C. J. (2010) · Journal of Statistical Theory and Practice · doi:10.1080/15598608.2010.10412022 · Cited by 9
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness
Pirro, M., Vaudo, G., Lupattelli, G., Pasqualini, L., Mannarino, M. R., Schillaci, G., Alaeddin, A., Paciullo, F., Fallarino, F., Bagaglia, F., et al. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.008 · Cited by 9
The role of conventional and novel mechanisms in explaining increased risk of cardiovascular events in offspring with positive parental history
Hamer, M., Chida, Y., & Stamatakis, E. A. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832f0d6f · Cited by 9
The Recent National Lipid Association Recommendations: How Do They Compare to Other Established Dyslipidemia Guidelines?
Flink, L. E., Underberg, J. A., Newman, J. D., & Gianos, E. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0494-9 · Cited by 9
Presence of external carotid artery plaque independently predicts mortality in patients without internal carotid artery atherosclerosis
Kim, E. S. H., Marycz, D. M., Archinal, D., Gornik, H. L., Shishehbor, M. H., & Bartholomew, J. R. (2014) · Vascular Medicine · doi:10.1177/1358863x14546159 · Cited by 9
Cardiovascular Disease as a Result of the Interactions Between Obesity, Climate Change, and Inflammation: The COCCI Syndemic
Clearfield, M. B., Davis, G. E., Weis, J., Gayer, G. G., & Shubrook, J. H. (2018) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2018.157 · Cited by 10
Vascular risk screening: possible or too much, too soon?
Wierzbicki, A. S., & Reynolds, T. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02111.x · Cited by 9
Commentary: C-reactive protein and risk prediction--moving beyond associations to assessing predictive utility and clinical usefulness
Vasan, R. S. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn353 · Cited by 9
Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients
Pappas, D. A., Reed, G. W., Kane, K., Curtis, J. R., Charles‐Schoeman, C., Giles, J. T., & Kremer, J. M. (2024) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2024.152504 · Cited by 9
External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study
Hughes, D. M., Yiu, Z. Z. N., & Zhao, S. S. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07325-y · Cited by 8
Predictive Accuracy of the European Society of Cardiology SCORE Among French People
Bérard, E., Séguro, F., Bongard, V., Dallongeville, J., Arveiler, D., Amouyel, P., Wagner, A., Ruidavets, J., & Ferrières, J. (2015) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000148 · Cited by 9
Blood Pressure Variability in Pregnancy: an Opportunity to Develop Improved Prognostic and Risk Assessment Tools
Vermunt, J. V., Kennedy, S., & Garovic, V. D. (2020) · Current Hypertension Reports · doi:10.1007/s11906-019-1014-z · Cited by 8
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Translation in to Russian
Moons, K. G. M., Altman, D. G., Reitsma, J. B., loannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, P. G. S. (2022) · Digital Diagnostics · doi:10.17816/dd110794 · Cited by 10
Health and fertility of ICSI-conceived young men: study protocol
Catford, S. R., Lewis, S., Halliday, J. L., Kennedy, J., O’Bryan, M. K., McBain, J., Amor, D. J., Rombauts, L. J. F., Saffery, R., Hart, R. J., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa042 · Cited by 8
Innovation in the design of large-scale hybrid randomized clinical trials
Rist, P. M., Sesso, H. D., & Manson, J. E. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106178 · Cited by 8
Assessment of cardiovascular risk in patients with crystal-induced arthritides and rheumatoid arthritis by the ATP III and Reynolds Risk Score
Елисеев, М. С., Novikova, A. M., Zhelyabina, O. V., Герасимова, Е. В., Ilyinykh, E. V., Попкова, Т. В., Паневин, Т. С., & Nasonov, E. L. (2020) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2020-512-519 · Cited by 8
Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus
Quintana, R., Pons‐Estel, G., Serrano, R., Pons‐Estel, B. A., & Bruce, I. N. (2021) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2021.03.002 · Cited by 8
Guía de práctica clínica para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias: evaluación del riesgo cardiovascular
Múñoz, Ó., Peña, Á. A. G., Fernández-Ávila, D. G., Higuera, A. M., Ruiz, Á. J., Aschner, P. J., Toro, J. M., Arteaga, J. M., Merchán, A., Sánchez, G., et al. (2015) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2015.04.009 · Cited by 12
Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation
Percy, A. J., Byrns, S., Chambers, A. G., & Borchers, C. H. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.856763 · Cited by 8
Improving risk factor modification: A global approach
Muchiteni, T., & Borden, W. B. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0068-y · Cited by 8
Cardiovascular disease, statins and vitamin D
Wilding, P. M. (2012) · British Journal of Nursing · doi:10.12968/bjon.2012.21.4.214 · Cited by 8
Natural History of Treated and Untreated Hypertension
Volpe, M., & Savoia, C. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_4 · Cited by 8
Time for a Policy Change for Coronary Artery Calcium Testing in Asymptomatic People?
Greenland, P., & Polonsky, T. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.048 · Cited by 8
Cardiovascular Risk Prediction in Older Adults
Colantonio, L. D., & Bittner, V. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01339-2 · Cited by 9
C-reactive protein and coronary heart disease - risk marker or risk factor?
Davis, F. J., Vidyasagar, S., & Maiya, G. A. (2012) · The Journal of Clinical and Scientific Research · doi:10.15380/2277-5706.jcsr.12.040 · Cited by 7
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.
Chao, T.-H., Lin, T., Cheng, C., Wu, Y., Ueng, K., Wu, Y., Lin, W.-W., Leu, H.-B., Cheng, H., Huang, C., et al. (2024) · PubMed Central · doi:10.6515/acs.202409_40(5).20240724a · Cited by 7
Estratificación del riesgo cardiovascular: importancia y aplicaciones
Ezquerra, E. A., Barrero, A. A., & Barrero, E. (2012) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(12)70039-0 · Cited by 10
Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy
Pinto, C. A., Tervonen, T., Marsh, K., Lambrelli, D., Schultze, A., Tershakovec, A. M., Hyacinthe, J., Prawitz, T., & Hammad, T. A. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4752 · Cited by 7
Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study
Kokkinos, A. D., Liaskos, C., Αλεξιάδου, Κ., Papassotiriou, I., Margeli, A., Argyrakopoulou, G., Perrea, D. N., Alexandrou, A. P., Katsilambros, N. L., Diamantis, T., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01358-7 · Cited by 7
Utility of Cardiovascular Imaging to Refine Cardiovascular Disease (CVD) Risk Assessment
Bittencourt, M. S., Hulten, E. A., Nasir, K., & Blankstein, R. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0378-5 · Cited by 7
A simple adaptation method improved the interpretability of prediction models for composite end points
Gondrie, M. J. A., Janssen, K. J. M., Moons, K. G. M., & van der Graaf, Y. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.021 · Cited by 7
Cardiovascular risk scores: Usefulness and limitations
Rocha, E. (2016) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2015.12.018 · Cited by 7
Foundation/American Heart Association Task Force on Practice Guidelines Asymptomatic Adults : A Report of the American College of Cardiology 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in
Smith, S. C., Taylor, A. J., Weintraub, W. S., Kushner, F. G., Lauer, M. S., Benjamin, J. M., Budoff, M. J., Fayad, Z. A., Foster, E., Greenland, P., et al. (2011) · Cited by 7
Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update
Labos, C., & Thanassoulis, G. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0980-0 · Cited by 7
Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention Trial
Plante, T., Juraschek, S., Zakai, N., Tracy, R., & Cushman, M. (2019) · American Journal of Cardiology · doi:10.1016/j.amjcard.2019.08.028 · Cited by 5
Cardiovascular risk factors in patients with calcium pyrophosphate crystal deposition disease
Елисеев, М. С., Zhelyabina, O. V., Chikina, M. N., & Novikova, A. M. (2019) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2019-545-552 · Cited by 7
Infections and cardiovascular disease: is Bartonella henselae contributing to this matter?
Salvatore, P., Zullo, A., Sommese, L., Colicchio, R., Picascia, A., Schiano, C., Mancini, F. P., & Claudio Napoli, A. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000099 · Cited by 7
Cardiovascular Risk Prediction using JBS3 Tool: A Kerala based Study
Paul, P., George, N., & Shan, B. P. (2020) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405616666200103144559 · Cited by 9
Translating Genomic Analyses into Improved Management of Coronary Artery Disease
Johansen, C. T., Lanktree, M. B., & Hegele, R. A. (2010) · Future Cardiology · doi:10.2217/fca.10.28 · Cited by 7
The Year in Atherothrombosis
Sanz, J., Moreno, P., & Fuster, V. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.047 · Cited by 8
Improving secondary cardiovascular risk prediction: taking a few steps along the long path from probability toward certainty
Anderson, J. L. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx386 · Cited by 7
The role of systemic inflammation in heart failure
Khazova, E. V., & Bulashova, O. V. (2021) · Kazan medical journal · doi:10.17816/kmj2021-510 · Cited by 6
Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study
Nomali, M., Yaseri, M., Nedjat, S., Azizi, F., Mansournia, M. A., Navid, H., Danaei, G., Woodward, M., Fahimfar, N., Steyerberg, E. W., et al. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111736 · Cited by 6
Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, S. C., Södergren, A., Semb, A. G., Kitas, G. D., Sattar, N. A., & Nurmohamed, M. T. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215748 · Cited by 6
Application of cardiovascular risk scales to identify carotid atherosclerosis in patients with rheumatoid arthritis
Владимировна, Г. Е., Попкова, Т. В., Gerasimova, D. A., Glukhova, S. I., Nasonov, E. L., & Lila, A. M. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.05.200787 · Cited by 6
Model for Predicting Cardiovascular Disease: Insights from a Korean Cardiovascular Risk Model
Park, G., & Kim, Y. (2015) · Pulse · doi:10.1159/000438683 · Cited by 6
Prevalence and risk of cardiovascular risk factors and events in offspring of patients at high vascular risk and effect of location of parental vascular disease
Weijmans, M., van der Graaf, Y., de Borst, G. J., Asselbergs, F. W., Cramer, M. J., Algra, A., & Visseren, F. L. J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.059 · Cited by 6
Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease
Mittleman, M. A., Taylor, W. C., Smetana, G. W., & Burns, R. B. (2015) · Annals of Internal Medicine · doi:10.7326/m15-1125 · Cited by 6
Hypertriglyceridemic waist: missing piece of the global cardiovascular risk assessment puzzle?
Arsenault, B. J., Després, J., & Boekholdt, S. M. (2011) · Clinical Lipidology · doi:10.2217/clp.11.51 · Cited by 6
Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis?
Purcărea, A., Sovaila, S., Gheorghe, A., Udrea, G., & Stoica, V. (2014) · Europe PMC (PubMed Central) · Cited by 6
Electronic Health Records and Evidence-Based Practice: Solving the Little-Data Problem
Flach, J. M., Schanely, P., Kuenneke, L., Chidoro, B., Mubaslat, J. S., & Howard, B. K. (2018) · Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care · doi:10.1177/2327857918071002 · Cited by 6
Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail
Fiolet, A. T. L., Opstal, T. S. J., Silvis, M. J. M., Cornel, J. H., & Mosterd, A. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01605-3 · Cited by 6
Cardiovascular risk reduction in referrals to outpatient vascular clinics
Stather, P., Muscara, F., Benson, R. A., Blackwell, J., Bootun, R., Bosanquet, D. C., Brooke, P., Busuttil, A., Coupland, A., Dattani, N., et al. (2017) · Annals of The Royal College of Surgeons of England · doi:10.1308/rcsann.2017.0204 · Cited by 6
Cardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction models
Mehta, S., Jackson, R., Wells, S., Harrison, J., Exeter, D. J., & Kerr, A. (2018) · Clinical Epidemiology · doi:10.2147/clep.s138100 · Cited by 6
Determinación del riesgo cardiovascular total. Caracterización, modelización y objetivos de la prevención según el contexto sociogeográfico
Elosúa, R., & Salinas, A. M. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)15002-5 · Cited by 6
Hs-CRP/ALB Levels Are Associated With Poor Long-term Prognosis in Patients With STEMI Undergoing Percutaneous Coronary Intervention
Li, M., Zhang, Y., Cui, X., Lang, J., & Hu, Y. (2025) · Angiology · doi:10.1177/00033197251322935 · Cited by 7
Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set
Li, M., Lin, Y., Zhong, X., Huang, R., Zhang, S., Liu, M., Liu, S., Ye, X., Xu, X., Huang, Y., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad106 · Cited by 6
Prediction of the 10-Year Risk of Cardiovascular Diseases Among Patients in Primary Health Care Centers in Eastern Province, Saudi Arabia
Almulhim, M., Alqattan, J., Almajed, A., AlKhars, M. A., Alhafith, A. A., Alajmi, M. S., Alhussain, R., Ali, S. I., Elsheikh, E., & Sahlawi, M. A. A. (2023) · Cureus · doi:10.7759/cureus.47551 · Cited by 5
Optimizing Cardiovascular Health: A Comprehensive Review of Risk Assessment Strategies for Primary Prevention
Karwa, V., Wanjari, A., Kumar, S., Dhondge, R. H., Patil, R., & Kothari, M. (2024) · Cureus · doi:10.7759/cureus.66341 · Cited by 8
Prevalence and severity of coronary artery disease in asymptomatic military air crew in the Netherlands: a prospective, cross-sectional study (SUSPECT)
Frijters, E., Nathoe, H. M., Grobben, R. G., Broekhuizen, L., Rienks, R., & Velthuis, B. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100250 · Cited by 4
Soluble Tumor Necrosis Factor Receptor 1 is Associated With Cardiovascular Risk in Persons With Coronary Artery Calcium Score of Zero
Dong, T., Bevan, G. H., Zidar, D. A., Cainzos‐Achirica, M., Nasir, K., Rashid, I., Rajagopalan, S., & Al-Kindi, S. G. (2021) · Pathogens and Immunity · doi:10.20411/pai.v6i2.477 · Cited by 6
Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection
Graham, S. M., Nance, R. M., Chen, J., Wurfel, M. M., Hunt, P. W., Heckbert, S. R., Budoff, M. J., Moore, R. D., Jacobson, J. M., Martin, J. N., et al. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003207 · Cited by 5
Use of biomarkers of metals to improve prediction performance of cardiovascular disease mortality
Fansler, S. D., Bakulski, K. M., Park, S. K., Walker, E., & Wang, X. (2024) · Environmental Health · doi:10.1186/s12940-024-01137-4 · Cited by 5
Proteína C reactiva y enfermedad arterial coronaria
Álvarez, F. D. L. C. H., González, A. P., Dopico, R. R., & Grek, O. G. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Strategies for treating lipids for prevention: Risk stratification models with and without imaging
Okwuosa, T. M., Mallikethi‐Reddy, S., & Lloyd‐Jones, D. M. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.01.004 · Cited by 5
Cardiovascular Risk Factor Screening Satisfaction in the Heart of New Ulm Project
Bekwelem, W., VanWormer, J. J., Boucher, J. L., & Pereira, R. F. (2011) · Clinical Medicine & Research · doi:10.3121/cmr.2011.1011 · Cited by 5
Relation of Alanine Aminotransferase Levels to Cardiovascular Events and Statin Efficacy
Harada, P. H. N., Cook, N. R., Cohen, D. E., Paynter, N. P., Rose, L. M., & Ridker, P. M. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.04.012 · Cited by 5
Self-citation
The Boehringer Ingelheim employee study (Part 2): 10-year cardiovascular diseases risk estimation
Kempf, K., Martin, S., Döhring, C., Dugi, K. A., Haastert, B., & Schneider, M. (2016) · Occupational Medicine · doi:10.1093/occmed/kqw084 · Cited by 6
Noninvasive detection of perivascular inflammation by coronary computed tomography in the CRISP-CT study and its implications for residual cardiovascular risk
Desai, M. Y. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy282 · Cited by 5
Familial history of heart disease and increased risk for elevated troponin in apparently healthy individuals
Cohen, N., Brzezinski, R. Y., Ehrenwald, M., Shapira, I., Zeltser, D., Berliner, S. A., Shenhar‐Tsarfaty, S., Milwidsky, A., & Rogowski, O. (2019) · Clinical Cardiology · doi:10.1002/clc.23214 · Cited by 5
Inflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: A New Focus on Prevention
Quispe, R., Varghese, B. T., & Michos, E. D. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_13 · Cited by 5
Central obesity and smoking are key modifiable risk factors for elevated C-reactive protein in Asian individuals who are not eligible for statin therapy
Khoo, C. M., Tan, M., Wu, Y., Wai, C. H., Subramaniam, T., Lee, J. Y., & Tai, E. S. (2011) · Nutrition and Diabetes · doi:10.1038/nutd.2011.4 · Cited by 5
The population effects of the global cardiovascular risk model in United States Adults: Findings from the National Health and Nutrition Surveys, 2005–2006
Tattersall, M. C., Karmali, K. N., Gangnon, R. E., & Keevil, J. G. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.007 · Cited by 5
Public health impact of statin prescribing strategies based on JUPITER
Nanchen, D., Pletcher, M. J., Cornuz, J., Marques-Vidal, P. M., Paccaud, F. M., Waeber, G., Vollenweider, P., & Rodondi, N. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.11.018 · Cited by 5
Should Statin Therapy Be Allocated on the Basis of Global Risk or on the Basis of Randomized Trial Evidence?
DeMazumder, D., Hasan, R. K., Blumenthal, R. S., Michos, E. D., & Jones, S. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.015 · Cited by 5
N-Terminal Pro–B-Type Natriuretic Peptide
Douglas, P. S., & Felker, G. M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1209 · Cited by 5
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial
Nicholls, S. J., Ray, K. K., Lincoff, A. M., Sarnes, E., Gillard, K. K., Bloedon, L., Migliaccio-Walle, K., Elsea, D., & Nissen, S. E. (2026) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-025-00753-w · Cited by 4
High-sensitivity C-reactive protein and cardiovascular events in a multi-ethnic cohort: the HELIUS study
Beverloo, C. Y. Y., Annink, M. E., Kraaijenhof, J. M., Reeskamp, L. F., Galenkamp, H., van den Born, B. H., Stroes, E. S. G., & Nurmohamed, N. S. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf740 · Cited by 4
Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction
de Bakker, M., Gordon, B., Shah, A. S. V., Boersma, E. H., & Kimenai, D. M. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf764 · Cited by 6
Cardiovascular risk stratification in inflammatory-driven conditions: how far have we come?
Silva, G. L. R., Sposito, A. C., Coelho‐Filho, O. R., & Quinaglia, T. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1601800 · Cited by 5
Evaluating the predictive performance of malaria antibodies and FCGR3B gene polymorphisms on Plasmodium falciparum infection outcome: a prospective cohort study
Dwomoh, D., Adu, B., Dodoo, D., Theisen, M., Iddi, S., & Gerds, T. A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03381-8 · Cited by 4
Community-Based Screening: Identifying Risk and Motivating Healthy Lifestyle Changes
Weisman, S. M., & Manganaro, A. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2675 · Cited by 4
Panoptic Total Cardiovascular Risk Prediction Using All Predictors Versus Optimized Risk Assessment Using Variable Subsets
Horne, B. D., Knight, S., & May, H. T. (2012) · Future Cardiology · doi:10.2217/fca.12.49 · Cited by 4
Hot and bothered: C-reactive protein, inflammation and atherosclerosis
Wierzbicki, A. S. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02211.x · Cited by 4
Predictive Value of Circulating Vascular Endothelial Growth Factor-1 in Arterial Hypertension Patients
Berezin, A. Е. (2013) · Internal Medicine Open Access · doi:10.4172/2165-8048.s11-006 · Cited by 4
Predictive Value of Circulating Vascular Endothelial Growth Factor-1 Level Measured Repeatedly During Long-Term Follow-Up in Patients with Arterial Hypertension after Acute Ischemic Stroke
Berezin, A. Е. (2014) · Angiology Open Access · doi:10.4172/2329-9495.1000119 · Cited by 4
Atherosclerosis
Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00008-2 · Cited by 4
Managing Cardiovascular Complications in Diabetes
Betteridge, J. D., & Nicholls, S. J. (2014) · Wiley eBooks · doi:10.1002/9781118337967 · Cited by 5
Cardiovascular Risk Calculators and their Applicability to South Asians
Bansal, M., Ranjan, S., & Kasliwal, R. R. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816999201001204020 · Cited by 5
Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
Steenhuis, D., de Vos, S., Bos, J., & Hak, E. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/6587165 · Cited by 5
High-Sensitivity C-Reactive Protein and Statin Initiation
Trpković, A., Stanimirović, J., Rizzo, M., Resanović, I., Šoškić, S., Jevremović, D., & Isenović, E. R. (2014) · Angiology · doi:10.1177/0003319714543000 · Cited by 4
Health 2000 score – development and validation of a novel cardiovascular risk score
Johansson, J. K., Puukka, P. J., Niiranen, T., Varis, J., Peltonen, M., Salomaa, V. V., & Jula, A. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1183257 · Cited by 4

Authors: Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Ridker, Paul M
Paynter, Nina P.
Rifai, Nader
Gaziano, J. Michael
Cook, Nancy R.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2008-11-25
Volume: 118
Issue: 22
Pages: 2243-2251
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.108.814251
PMC: PMC2752381
OpenAlex: W2096807144
Semantic Scholar: 4e13b2445d617740f45915eafd75712fdf825998
Cited by: 841
References: 27
Citations by year: 2026: 11 · 2025: 22 · 2024: 20 · 2023: 25 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 39 · 2018: 42 · 2017: 37 · 2016: 47 · 2015: 68 · 2014: 63 · 2013: 53 · 2012: 92
FWCI: 80.90
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA097193)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: Reynolds Risk Score, cardiovascular risk prediction, men, family history of myocardial infarction, coronary artery disease, risk reclassification, net reclassification improvement, coronary risk factors, hypertriglyceridemia, hypercholesterolemia, LDL cholesterol, HDL cholesterol, blood pressure, smoking, non-diabetic men
MeSH terms: C-Reactive Protein, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Inflammation, Life Style, Male, Predictive Value of Tests, Prospective Studies, Sex Characteristics, Biomarkers, Likelihood Functions, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks